More importantly, although high exosomal ASMTL‐AS1 expression resulted in disappointing survival rates in HCC patients without RFA treatment, it gave rise to worse outcomes in those with insufficient RFA (Figure 7D). The gene discussed is ASMTL; the disease is hepatocellular carcinoma.